We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
27 hedge funds and large institutions have $62.9M invested in scPharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
41% more capital invested
Capital invested by funds: $44.5M → $62.9M (+$18.4M)
18.92% more ownership
Funds ownership: 40.78% → 59.7% (+19%)
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
4% more funds holding
Funds holding: 26 → 27 (+1)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
Holders
27
Holders Change
+1
Holders Change %
+3.85%
% of All Funds
0.53%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
5
Reduced
5
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$637K |
| 2 |
EP
Eversept Partners
New York
|
+$409K |
| 3 |
Squarepoint
New York
|
+$280K |
| 4 |
Renaissance Technologies
New York
|
+$264K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$16.5K |
Top Sellers
| 1 |
Northern Trust
Chicago,
Illinois
|
-$62K |
| 2 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$60K |
| 3 |
JP Morgan Chase
New York
|
-$44.2K |
| 4 |
Morgan Stanley
New York
|
-$25.8K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$24.5K |
